MFIC is looking to introduce a new microfluidic system that
could help pharmaceutical and biotechnology companies to
manufacture difficult to formulate drugs.
UK biotech firm Acambis has decided to bring the manufacturing of
its soon to be approved smallpox vaccine in-house while its
agreement with contract manufacturer Baxter comes to an end.
The latest Advances in Microarray Technology (AMT) conference, held
in conjunction with the Lab-on-a-Chip World Congress highlighted
the movement of the fields from the research lab into diagnostics.
Inovio Biomedical, a US company developing novel DNA
immunotherapies and other treatments based on electroporation
technology, has reported interim data from a Phase I/II clinical
study showing that its MedPulser system significantly...
YM BioSciences today announced that the upgraded manufacturing
facility for the firm's humanized monoclonal antibody (MAb) for the
treatment of cancer has successfully passed a series of regulatory
reviews.
Indian firm Alembic has landed a licensing deal with biopharma
heavyweight UCB to apply the company's novel drug delivery system
for a once-a-day version of UCB's market leading epilepsy drug.
Albany Molecular Research (AMRI) has followed up its push into new
markets for its drug discovery operations by tapping into the
well-established trend for sourcing contract pharmaceutical
manufacturing from the lower-cost Asian region.
A young start-up company is gearing up to challenge the likes of
Pfizer by developing a new insulin product, based on its novel
nano-based intranasal delivery technology.
Thailand is the first recipient of six major grants the World
Health Organization (WHO) is distributing to developing countries
to establish in-country manufacturing capacity for influenza
vaccine.
India-based Dr Reddy's Laboratories has boosted its revenue by 168
per cent for the 2006 year, fuelled by a strengthening position in
the international market.
Canada-based Draxis Health has passed a US Food and Drug
Administration (FDA) inspection with flying colours after
contracting out its manufacturing services to two new clients.
Novel tabletting technology developed by US company ACCU-BREAK Pharmaceuticals promises to solve the problem of uneven doses when pills are split by hand.
The first contract research service alliance (CROSA) in China has
been formed between three leading local firms to provide a more
exhaustive range of drug development services to pharma companies.
A non-invasive technique that uses hair plucked from cancer
patients to guide the development of new chemotherapy drugs has
attracted the attention of UK pharma giant AstraZeneca.
Arrayjet's new Sprint benchtop inkjet microarray spotter promises
to allow researchers the ability to design and print their own
microarrays and array-based biosensors.
An approvable letter for Shire's long-lasting formulation of its
best-selling attention deficit and hyperactivity disorder (ADHD)
drug Adderall is not the stumbling block it may appear says the
company.
Bosch Packaging Technology has launched the FLT1020 vial filling
system, a scaled-down version of full-sized filling units that is
geared specifically to use in the early stages of clinical trials.
Molecular Insight Pharmaceuticals is buying a commercial-scale
radiopharmaceutical manufacturing facility in Texas for $3m as it
moves towards increasing its manufacturing in the increasingly
profitable pharmaceutical area.
US company Alnylam Pharmaceuticals has consolidated its
relationship with researchers from the Massachusetts Institute of
Technology (MIT) by signing an agreement to sponsor a five-year
program at the Institute's Center for Cancer...
Thermo Fisher Scientific has released a series of modules for its
Nicolet 8700 FT-IR spectrometer to allow researchers to study fast
reaction processes, chiral molecules and molecular films.
Swiss drug major Roche is facing a delay in bringing its EPO drug
Mircera (continuous erythropoietin receptor activator) to market in
the US after the Food and Drug Administration sent it an
'approvable' notice for the product.
A white knight in the form of Indian-based Sun Pharmaceuticals, has
rescued an Israeli company from a looming financial crisis by
investing more than $400m in the company.
A firm specialising in disposable equipment for the
biopharmaceutical industry has introduced a new revamped bioreactor
to its catalogue, dispensing with the traditional rocking and
rolling mechanisms used in many bioreactors.
The significance of the aborted deal between GlaxoSmithKline and
Cobra has been exaggerated due to GSK's high profile and is not the
end of the world, the British contract manufacturer said.
Solvay's Epicerol process for manufacturing the chemical
intermediate epichlorohydrin from glycerine won the Belgian company
the 2007 Glycerine Innovation Award at the Annual Meeting and Expo
of the American Oil Chemists'...
A UK-based technology company is part of a trio leading the way in
innovative supply chain solutions by combining real-time
temperature monitoring with a radio frequency identification (RFID)
tag for the pharmaceutical industry.
Anglo-German firm Evotec is taking its fragment-based drug
discovery (FBDD) services a step further with the launch today of a
new innovation centre for FBDD.
A live attenuated replication-defective vaccine against the
influenza virus has started a Phase I clinical trial at the Medical
University of Vienna in Austria.
An animal model used to evaluate vaccines could be "far more
useful" to predict potential side effects than current methods,
according to its developers, AMDL.
The critical role transgenic animals could play in the future of
biopharmaceutical production has been tackled by a task force in a
new report out this week.
Advanced Research Technologies (ART) has launched a new imaging
system for studying molecular events in small living animals to
further our understanding of disease and treatment mechanisms.
A company that specialises in designing first-in-class small
molecule drugs that modulate ion channels has been given an award
for its innovative preclinical research.
Siemens is offering software support for the implementation of
Process Analytical Technology (PAT) in the pharmaceutical industry
with the launch of its Sipat package.
The decision of the US Supreme Court not to hear Amgen's appeal in
a patent infringement case against Sanofi-Aventis and Shire,
involving the anaemia drug Epogen (epoetin alfa), may weaken
Amgen's position in keeping another...
US company Digestive Care (DCI) is quadrupling its manufacturing,
research and development capacity following an increase in demand
for its drug Pancrecarb (pancrelipase).
Clinsys Clinical Research, BioReliance Corporation, InVentiv
Health, PRA International, Kendle, Parexel, PPD, Wyeth and
PharmaNet have all had people on the move in the world of
pharmaceutical outsourcing.
Swiss contract manufacturer Lonza has decided to merge its US
microbial biopharma business activities in a single location, three
months after buying Cambrex's biopharma unit.
Thermo Fisher Scientific and Sartorius have signed a supply
agreement continuing the relationship between Sartorius and
Thermo's recently acquired TC Tech.
US contract manufacturer Albemarle has announced it will move
operations of its pilot plant in Ohio to its recently acquired
manufacturing facility in Michigan.
Outsourced pharmaceutical R&D spending is set to increase
at twice the expected rate of general R&D expenditure
for the next five years, according to new research published this
week.
Bacterially derived nanocells that can deliver chemotherapeutic
drugs directly to cancer cells without the shortcomings of
liposomal or viral carriers could be in clinical trials by the end
of this year, an Australian biotechnology...
The race to put the first cancer therapy based on RNA interference
(RNAi) technology into clinical trials has heated up with one
developer claiming it is almost ready to go.
Contract manufacturer Granules India is moving towards vertical
integration, with a new tabletting facility scheduled to come
onstream this August at the company's Gagillapur site near
Hyderabad in India.
India's Lupin Ltd is ramping up its active pharmaceutical
ingredient (API) capability by teaming up with compatriot and
corticosteroid specialist Symbiotec Pharmalab Ltd.
